Sources | Names Used |
---|---|
CTRPv2 | compound 1B |
PharmacoGx | compound 1B |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | C19orf53 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.06 |
mRNA | KCTD9 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.06 |
mRNA | SUV39H1 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.06 |
mRNA | GAGE12B | CTRPv2 | pan-cancer | AAC | -0.07 | 0.06 |
mRNA | TTC37 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.06 |
mRNA | SLC25A11 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.06 |
mRNA | HDAC8 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.06 |
mRNA | MFSD14B | CTRPv2 | pan-cancer | AAC | 0.072 | 0.06 |
mRNA | SLC2A4 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.06 |
mRNA | IRX2 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.06 |